Small smiles of satisfaction spread around the staff in my office last week. The NIH Guide published the last of our long-running saga of funding opportunity announcements (FOAs) on Alzheimer’s disease and Alzheimer’s-related dementias (ADRD). These were the concepts that the National Advisory Council on Aging approved last September (Thank you again, everyone!).
The mighty push for research on Alzheimer’s disease and related dementias continues at NIA. While an earlier blog highlighted the research initiatives we have published, this chapter covers the more recent publication of two training initiatives and four small business-related initiatives.
If we hope to translate what we are learning about Alzheimer’s disease into health, safety, and emotional well-being benefits for Alzheimer’s patients and their families, then small businesses have a vital role in making that happen. The NIA recently published two funding opportunity announcements for small businesses focused on Alzheimer’s disease. One targets the Small Business Innovative Research program and the other the Small Business Technology Transfer program. Both have an initial submission date approaching rapidly—April 5. And if peer reviewers smile upon your application, you can even receive funding before the end of September this year.
Most government funding agencies, including the NIH, have special pots of money reserved for small businesses. “But M-D,” you say, “I’m in academia, I’m a scientist—what does business funding have to do with me?” But before you dismiss this funding opportunity, I invite you to look a little more closely.